• CVS lifted 2026 outlook, targeting total revenue of at least USD 405 billion, adjusted operating income of USD 15.53 billion to USD 15.87 billion, adjusted EPS of USD 7.3 to USD 7.5, GAAP EPS of USD 6.24 to USD 6.44.
• Cash flow from operations forecast at least USD 9.5 billion.
• Health Care Benefits segment revenue seen at least USD 142 billion, adjusted operating income of USD 4 billion to USD 4.34 billion, medical membership about 26 million, medical benefits ratio 90.5% ± 50 bps.
• Health Services segment outlook maintained, with revenue at least USD 196.6 billion, adjusted operating income at least USD 7.25 billion, pharmacy claims processed at least 1.
• Pharmacy & Consumer Wellness revenue expected at least USD 136.5 billion, adjusted operating income at least USD 6.18 billion, prescriptions filled at least 1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.